Levilactobacillus Brevis + Oritavancin Diphosphate
Oritavancin Diphosphate brand names: Orbactiv, Kimyrsa.
Levilactobacillus Brevis has a moderate interaction with Oritavancin Diphosphate. Theoretically, taking Levilactobacillus brevis with antibiotic drugs might decrease the effectiveness of L.
Read the full interaction reportLevilactobacillus Brevis and Oritavancin Diphosphate
Here is the interaction we found between these two, with the evidence behind it.
ANTIBIOTIC DRUGS
Why this applies to Oritavancin Diphosphate
Oritavancin Diphosphate falls under ANTIBIOTIC DRUGS — the group Levilactobacillus Brevis interacts with.
Levilactobacillus brevis preparations usually contain live and active organisms. Therefore, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and L. brevis preparations by at least two hours.
Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports..
Here's the simple version: oritavancin (Orbactiv or Kimyrsa) is a powerful antibiotic given as an IV infusion, and its whole job is to kill bacteria. The catch is that a probiotic like Levilactobacillus brevis is made of live, helpful bacteria. The antibiotic can't tell the good bugs from the bad ones, so it may wipe out a good chunk of the probiotic, leaving you with less benefit from it.
This concern is theoretical, based on how these products work, not on strong studies, so it isn't dangerous. The probiotic won't make your antibiotic weaker or cause new side effects. One nice thing about oritavancin is that it's usually a single dose, so any overlap is brief. Still, to get the most from your probiotic, it's reasonable to space the two apart and check timing with your pharmacist or doctor.
- Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
What These Ratings Mean
Every interaction above is graded three ways — here’s the key to each label.
Clinically significant. Avoid the combination, or use only under close professional supervision.
Usually worth avoiding or managing — may need monitoring, a dose change, or timing apart.
Generally not serious. Be aware of it and mention it to your pharmacist.
- LikelyWell-controlled human studies have demonstrated the likely existence of this interaction.
- ProbableInteraction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- PossibleInteraction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
- UnlikelyInteraction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
- AHigh-quality meta-analysis (quantitative systematic review).
- BCase-control study.
- CConsensus.
- DAnecdotal evidence.
These ratings are for information only. Never start, stop, or otherwise change your therapy before speaking with your provider.
Levilactobacillus Brevis Also Interacts With Other Medications
Levilactobacillus Brevis has 181 moderate known drug interactions in our database — the Oritavancin Diphosphate one above is one of them. If you take anything else, check it against the full list below.
Check Another of Your Medications Against Levilactobacillus Brevis
We haven’t checked that one against Levilactobacillus Brevis yet — ask our pharmacists directly.
Covers the 2,830 medications we’ve checked against Levilactobacillus Brevis. Pick one to open its full report.
See Every Supplement That Interacts With Oritavancin Diphosphate
This page covers Levilactobacillus Brevis only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Oritavancin Diphosphate page lists 48 supplements it has a documented interaction with, worst first, each one explained.
The most serious there right now: Alkanna (moderate), Alpine Ragwort (moderate), Bacillus Coagulans (moderate), Bacillus Subtilis (moderate) and Bifidobacterium Animalis Subsp. Lactis (moderate).
By severity: 47 moderate · 1 minor.
From our pharmacist’s overview on the Oritavancin Diphosphate page
“Oritavancin (Orbactiv, Kimyrsa) is a long-acting antibiotic given as a single IV infusion for serious skin infections, and because one dose stays in the body for days, supplement timing matters more than usual. Even so, none of the 48 ingredients on file rise past moderate, so for most people this list is about knowing what to watch ra…”
Reviewed by 2 · Jul 18, 2026
Where Levilactobacillus Brevis and Oritavancin Diphosphate Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#759 of 1,452 supplements looked up here in the last 7 days
#2,299 of 2,830 medications looked up here in the last 7 days
Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.
About Levilactobacillus Brevis
What is Levilactobacillus Brevis?
- Digestive health
- Gut microbiome support
- Immune support
- Oral and dental health
- Vaginal health
Levilactobacillus brevis (formerly Lactobacillus brevis) is a lactic acid bacterium found in fermented foods like sauerkraut, pickles, and kimchi, and is used as a probiotic. Early research suggests possible benefits for gut and immune health, but strong human evidence is still limited. It is generally well tolerated in healthy people, but anyone with a weakened immune system or serious illness should talk to a doctor first.
About Oritavancin Injection
What Is Oritavancin Injection Used For?
Brand names: Orbactiv, Kimyrsa
Oritavancin injection — available as Orbactiv and Kimyrsa — is used to treat acute bacterial skin and skin structure infections (ABSSSI) in adults. These are serious skin infections caused by susceptible gram-positive bacteria, including Staphylococcus aureus (including MRSA), several Streptococcus species, and vancomycin-susceptible Enterococcus faecalis.
This antibiotic should only be used when a bacterial infection is confirmed or strongly suspected. Using it unnecessarily can contribute to antibiotic resistance.
Other Drugs & Levilactobacillus Brevis
Browse every other medication we’ve checked against Levilactobacillus Brevis — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
181 interactions
- Metronidazole ›
- Doxycycline ›
- Erythromycin ›
- Minocycline ›
- Tetracycline ›
- Amoxicillin ›
- Ciprofloxacin ›
- Penicillin V Potassium ›
- Ampicillin ›
- Ceftazidime ›
- Clindamycin ›
- Penicillin G Potassium ›
- Cephalexin ›
- Dicloxacillin Sodium ›
- Nitrofurantoin ›
- Ofloxacin ›
- Rifampin ›
- Tobramycin ›
- Azithromycin ›
- Bacitracin ›
- Cefadroxil ›
- Cefuroxime ›
- Chloramphenicol ›
- Cloxacillin Sodium ›
- Dapsone ›
- Doxycycline Hyclate ›
- Erythromycin Ethylsuccinate ›
- Erythromycin Stearate ›
- Levofloxacin ›
- Neomycin ›
- Amikacin ›
- Cefaclor ›
- Cephradine ›
- Clarithromycin ›
- Cyclacillin ›
- Daptomycin ›
- Gatifloxacin ›
- Lincomycin Hcl ›
- Linezolid ›
- Methenamine Hippurate ›
- Methenamine Mandelate ›
- Minocycline Hydrochloride ›
- Norfloxacin ›
- Oxacillin ›
- Penicillin G Benzathine ›
- Retapamulin ›
- Trimethoprim ›
- Trovafloxacin ›
- Vancomycin ›
- Amoxicillin Veterinary ›
- Aztreonam ›
- Bacampicillin ›
- Benznidazole ›
- Capreomycin ›
- Carbenicillin Indanyl Sodium ›
- Cefamandole ›
- Cefazolin ›
- Cefdinir ›
- Cefditoren Pivoxil ›
- Cefepime ›
Showing 60 of 181 moderate interactions — see all 181 on the Levilactobacillus Brevis page.
No interaction 2,648 drugs checked — show the list
We also checked Levilactobacillus Brevis against these medications and found no known interaction in our sources. Open any page to confirm.
- Apixaban ›
- Levothyroxine ›
- Amlodipine ›
- Methylphenidate ›
- Warfarin ›
- Sertraline ›
- Testosterone ›
- Losartan Potassium ›
- Metoprolol ›
- Aspirin ›
- Ivermectin ›
- Rivaroxaban ›
- Rosuvastatin ›
- Escitalopram ›
- Tadalafil ›
- Acetaminophen ›
- Clopidogrel ›
- Valacyclovir ›
- Atorvastatin ›
- Docusate ›
- Hydroxyurea ›
- Abemaciclib ›
- Methamphetamine ›
- Sumatriptan ›
- Ibuprofen ›
- Semaglutide ›
- Tirzepatide ›
- Warfarin Sodium ›
- Prednisone ›
- Propranolol ›
- Lisdexamfetamine ›
- Acyclovir ›
- Bupropion ›
- Metformin ›
- Lisinopril ›
- Bendamustine ›
- Amitriptyline ›
- Lamotrigine ›
- Fluoxetine ›
- Methotrexate ›
- Acetaminophen, Codeine ›
- Gabapentin ›
- Amphetamine ›
- Pregabalin ›
- Isotretinoin ›
- Dextroamphetamine ›
- Clonazepam ›
- Quetiapine ›
- Omeprazole ›
- Amlodipine Besylate ›
- Methylene Blue ›
- Duloxetine ›
- Letrozole ›
- Buspirone ›
- Citalopram ›
- Naproxen ›
- Bisoprolol ›
- Levothyroxine, Liothyronine ›
- Acetaminophen, Oxycodone ›
- Diazepam ›
Showing the 60 most looked-up of 2,648 medications checked with no known interaction — see the full Levilactobacillus Brevis list.
Sources & How We Checked
Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference for vitamins, herbs and supplements — the basis for our interaction data.
- MedlinePlus, U.S. National Library of Medicine — NIH consumer drug information, used for the medication overviews.
- NIH Dietary Supplement Label Database (DSLD) — Official supplement product labels.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Oritavancin Diphosphate Is Linked to Lower Levels of 7 Nutrients
Natural Medicines records Oritavancin Diphosphate as a medicine that can lower these. This is not an interaction with Levilactobacillus Brevis — it is a separate effect of the medicine, and it is a reason some people are advised to supplement rather than to avoid one:
Read the full Oritavancin Diphosphate nutrient depletion report ›
Depletion records come from the licensed Natural Medicines database. Do not start a supplement on the strength of this page — ask your pharmacist or doctor whether it applies to you.
Taking Levilactobacillus Brevis and Oritavancin Diphosphate Together: Common Questions
Can you take Levilactobacillus Brevis with Oritavancin Diphosphate?
How serious is the Levilactobacillus Brevis and Oritavancin Diphosphate interaction?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Still Have a Question About Oritavancin Diphosphate and Levilactobacillus Brevis?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.